In our first installment of our biologicals series, we lay the groundwork by looking at what biologicals are and how they are used today.

We are excited to partner with ViAqua to transform aquaculture disease management and contribute to a more sustainable aquaculture sector.

We are thrilled to invest in TechMet, as it builds a platform to produce, manufacture and recycle critical for the energy transition.

In Part 2 of our Financing Pathways series, we examine when companies should look into non-dilutive capital, such as with climate tech.

The net zero transition will require bespoke, multi-party solutions among corporates, policymakers, innovators, academics, and financiers.

S2G's Chuck Templeton shares how businesses can minimize vulnerability to black swan events and his optimism for today's entrepreneurs.

As an alternative to equity financing, “non-dilutive” capital provides financing without reducing equity ownership.

We're excited to invest in Apeiron Labs, which is scaling upper ocean observation to transform our understanding of the state of our oceans.

We are excited to share our investment in Omeat as the company comes out of stealth mode to make cultivated meat more affordable and humane.

There were many enlightening perspectives from different angles offered at the summit, with a call for collaboration repeatedly mentioned.